Low-Cost Contingency Management for Hispanic Outpatients - 3 - Full Text View

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Connecticut Health Center
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00249548

Purpose

The purpose of this study is to evaluate the effectiveness of a lower-cost contingency management (CM) procedure in Hispanic substance abusing outpatients. Thirty individuals meeting DSM-IV criteria for substance dependence receive one of two conditions: (a) standard treatment, or (b) standard treatment plus prize CM. Using a cross-over design, CM is implemented in a community-based outpatient clinic and compared with non-CM in the same clinic. The participating clinic is randomly assigned to receive either the CM or non-CM phase first; 15 weeks after the final participant in one phase is enrolled, a one-week washout period occurs, followed by a switch to the other phase. Patients initiating outpatient treatment during the non-CM phase receive standard treatment and submit urine and breath samples 2/week during Weeks 1-6 and 1/week during Weeks 7-12. Patients initiating treatment during the CM phase also receive standard treatment and the same breath and urine monitoring. In addition, they earn the opportunity to win prizes for coming to treatment and for submitting negative breath and urine samples. Follow-up interviews are conducted at 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.

Condition	Intervention
Substance Abuse	Behavioral: Contingency management

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Crossover Assignment, Efficacy Study
Official Title:	Low-Cost Contingency Management for Hispanic Outpatients

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Drug use [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]

Enrollment:	30
Study Start Date:	August 2004
Study Completion Date:	January 2006
Primary Completion Date:	January 2006 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

age > 18 years
current DSM-IV substance dependence.

Exclusion criteria:

have a serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
have dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975)
DSM-IV diagnosis of pathological gambling
plans to move from the Hartford are within 9 months.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00249548

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Connecticut Health Center

Investigators

Principal Investigator:

Nancy Petry, Ph.D.

University of Connecticut Health Center

More Information

Responsible Party:	UConn Health Center ( Nancy Petry, Ph.D. )
Study ID Numbers:	NIDA-13444-3, R01-13444-3
Study First Received:	November 3, 2005
Last Updated:	May 23, 2008
ClinicalTrials.gov Identifier:	NCT00249548
Health Authority:	United States: Federal Government; United States: Institutional Review Board

Keywords provided by National Institute on Drug Abuse (NIDA):

contingency management
substance abuse

Study placed in the following topic categories:

Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on January 14, 2009